chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: dizziness; nausea; vomiting; fever; chills; fatigue; headache; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever) and CHILLS (chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and DIARRHOEA (diarrhea). At the time of the report, DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications reported were blood measure medication, thyroid medication, Symbicort 2 inhalers if needed and allergy medication Treatment information was not provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: dizziness; nausea; vomiting; fever; chills; fatigue; headache; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever) and CHILLS (chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and DIARRHOEA (diarrhea). At the time of the report, DIZZINESS (dizziness), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications reported were blood measure medication, thyroid medication, Symbicort 2 inhalers if needed and allergy medication Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Received vaccine and having a reaction to it; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Received vaccine and having a reaction to it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Received vaccine and having a reaction to it). At the time of the report, VACCINATION SITE REACTION (Received vaccine and having a reaction to it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment or concomitant medications were reported. No treatment information was reported.
Age: 47.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pain in extremity, Pyrexia, Rash, Skin warm, Vaccination site erythema
Clinical narrative: Itchy red and swollen knot at the site of injection; Itchy red and swollen knot at the site of injection; Itchy red and swollen knot at the site of injection; Fever; hot on the face; sore arm; Rash/rash on her face; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm), RASH (Rash/rash on her face) and VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) for an unknown indication.    Concurrent medical conditions included Penicillin allergy.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) (unknown route) at an unspecified dose. On 03-Feb-2021, the patient experienced PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm) and RASH (Rash/rash on her face). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection), VACCINATION SITE PRURITUS (Itchy red and swollen knot at the site of injection) and VACCINATION SITE SWELLING (Itchy red and swollen knot at the site of injection). At the time of the report, PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection) and VACCINATION SITE SWELLING (Itchy red and swollen knot at the site of injection) had not resolved and RASH (Rash/rash on her face) and VACCINATION SITE PRURITUS (Itchy red and swollen knot at the site of injection) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.
Age: 47.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy red and swollen knot at the site of injection; Itchy red and swollen knot at the site of injection; Itchy red and swollen knot at the site of injection; Fever; hot on the face; sore arm; Rash/rash on her face; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm), RASH (Rash/rash on her face) and VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) for an unknown indication.    Concurrent medical conditions included Penicillin allergy.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) (unknown route) at an unspecified dose. On 03-Feb-2021, the patient experienced PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm) and RASH (Rash/rash on her face). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection), VACCINATION SITE PRURITUS (Itchy red and swollen knot at the site of injection) and VACCINATION SITE SWELLING (Itchy red and swollen knot at the site of injection). At the time of the report, PYREXIA (Fever), SKIN WARM (hot on the face), PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (Itchy red and swollen knot at the site of injection) and VACCINATION SITE SWELLING (Itchy red and swollen knot at the site of injection) had not resolved and RASH (Rash/rash on her face) and VACCINATION SITE PRURITUS (Itchy red and swollen knot at the site of injection) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Myalgia, Vaccination site swelling
Clinical narrative: muscular pain; hardness; swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscular pain), FEELING ABNORMAL (hardness) and VACCINATION SITE SWELLING (swelling at injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced MYALGIA (muscular pain), FEELING ABNORMAL (hardness) and VACCINATION SITE SWELLING (swelling at injection site). At the time of the report, MYALGIA (muscular pain), FEELING ABNORMAL (hardness) and VACCINATION SITE SWELLING (swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pyrexia
Clinical narrative: Fever; Arthralgia; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ARTHRALGIA (Arthralgia), CHILLS (Chills) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (Fever), ARTHRALGIA (Arthralgia), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), ARTHRALGIA (Arthralgia), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medications were not provided.  Action taken with the drug in response to the events was not applicable.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain, Vaccination site erythema, Vaccination site lymphadenopathy, Vaccination site pruritus
Clinical narrative: Swelling at site of injection; tender at site of injection; headache; Hot at site of injection; Itching at site of injection; heat and pain even radiated up my neck toward my right ear; Injection site erythema; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (heat and pain even radiated up my neck toward my right ear), VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE PRURITUS (Itching at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (erythromycin) and Drug allergy (sulfa drugs). Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced NECK PAIN (heat and pain even radiated up my neck toward my right ear) and VACCINATION SITE ERYTHEMA (Injection site erythema). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at site of injection). On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) and HEADACHE (headache). On 21-Feb-2021, HEADACHE (headache) had resolved. On 25-Feb-2021, VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE PRURITUS (Itching at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) had resolved. At the time of the report, NECK PAIN (heat and pain even radiated up my neck toward my right ear) and VACCINATION SITE ERYTHEMA (Injection site erythema) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Two events were added and second dose information was added
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swelling at site of injection; tender at site of injection; headache; Hot at site of injection; Itching at site of injection; heat and pain even radiated up my neck toward my right ear; Injection site erythema; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (heat and pain even radiated up my neck toward my right ear), VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE PRURITUS (Itching at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (erythromycin) and Drug allergy (sulfa drugs). Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced NECK PAIN (heat and pain even radiated up my neck toward my right ear) and VACCINATION SITE ERYTHEMA (Injection site erythema). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at site of injection). On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) and HEADACHE (headache). On 21-Feb-2021, HEADACHE (headache) had resolved. On 25-Feb-2021, VACCINATION SITE WARMTH (Hot at site of injection), VACCINATION SITE PRURITUS (Itching at site of injection), VACCINATION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE LYMPHADENOPATHY (tender at site of injection) had resolved. At the time of the report, NECK PAIN (heat and pain even radiated up my neck toward my right ear) and VACCINATION SITE ERYTHEMA (Injection site erythema) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Two events were added and second dose information was added
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included CITALOPRAM, PRENATAL VITAMINS [ASCORBIC ACID; BETA CAROTENE; CALCIUM SULFATE; COLECALCIFEROL; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NICOTINAMIDE; PYRIDOXINE HYDROCHLORIDE; RETINOL ACETATE; RIBOFLAVIN; THIAMINE MONONITRATE; TOCOPHERYL ACETATE; ZINC OXIDE] and IRON for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jun-2020 and the estimated date of delivery was 16-Mar-2021. On 27-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-seventh week of the pregnancy.  On 27-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Internal review on 21-JUL-2021 resulted in update of Reporter details , Gestation period, Birth type , Fetal outcome, Action taken with suspect drug .
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Had reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Had reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Had reaction). At the time of the report, ADVERSE REACTION (Had reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: Blood pressure got to 194/97; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure got to 194/97) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 23-Mar-1954, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure got to 194/97). At the time of the report, BLOOD PRESSURE INCREASED (Blood pressure got to 194/97) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 194/97.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pain in extremity, Pruritus, Vaccination site infection
Clinical narrative: HCP believed it was an infection caused by the injection; Pain in her entire right leg; redness,Red spot on her arm that was hurting a lot; Reaction spread more and more and was hurting and itching; Aches,Pains all over; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over). The patient was treated with ANTIBIOTICS-RESISTANT LACTIC ACID BACTERIAE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-1 test positive
Clinical narrative: Father tested positive for covid 19 after receiving 1st dose; Father had no symptoms but he was tested positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Father tested positive for covid 19 after receiving 1st dose) and COVID-19 (Father had no symptoms but he was tested positive) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Feb-2021, the patient experienced COVID-19 (Father tested positive for covid 19 after receiving 1st dose) and COVID-19 (Father had no symptoms but he was tested positive). At the time of the report, COVID-19 (Father tested positive for covid 19 after receiving 1st dose) and COVID-19 (Father had no symptoms but he was tested positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, SARS-CoV-1 test positive: positive (Positive) Tested positive 17 days after receiving 1st dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.    This case was linked to MOD-2021-039688, MOD-2021-039511 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: diarrhea; Dizziness; Nausea; vomiting; fever; chills; fatigue; headache; This spontaneous case was reported by an other caregiver and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting) and PYREXIA (fever) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Cymbalta. Blood pressure medications. Treatment details were not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: diarrhea; Dizziness; Nausea; vomiting; fever; chills; fatigue; headache; This spontaneous case was reported by an other caregiver and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting) and PYREXIA (fever) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (Dizziness), NAUSEA (Nausea), VOMITING (vomiting), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Cymbalta. Blood pressure medications. Treatment details were not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Type IV hypersensitivity reaction, Vaccination site erythema
Clinical narrative: delayed; fever; chills; headache; itchy; redness; swelling; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (delayed), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE SWELLING (swelling) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness). 05-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling). On 26-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and HEADACHE (headache). On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (delayed). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (delayed), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE SWELLING (swelling), PYREXIA (fever), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      Concomitant medications were not provided.  Treatment information was not provided by reporter.   Action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: NNI
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: delayed; fever; chills; headache; itchy; redness; swelling; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (delayed), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE SWELLING (swelling) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness). 05-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling). On 26-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and HEADACHE (headache). On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (delayed). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (delayed), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE SWELLING (swelling), PYREXIA (fever), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      Concomitant medications were not provided.  Treatment information was not provided by reporter.   Action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: NNI
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site inflammation
Clinical narrative: Inflamed skin (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflamed skin (Injection Site)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Inflamed skin (Injection Site)). At the time of the report, VACCINATION SITE INFLAMMATION (Inflamed skin (Injection Site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: red circle around injection site; warmth at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle around injection site) and VACCINATION SITE WARMTH (warmth at injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included HYDROCHLOROTHIAZIDE, ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITE), ASPIRIN [ACETYLSALICYLIC ACID], LISINOPRIL, PRAVASTATIN, MULTIVITAMIN [VITAMINS NOS] and CALCIUM for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle around injection site) and VACCINATION SITE WARMTH (warmth at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red circle around injection site) and VACCINATION SITE WARMTH (warmth at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include Bioflexin and a stool softener, not otherwise specified. No treatment details reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination site rash
Clinical narrative: chills; fever; body aches; Patient noticed a raised red rash on injection site 3 days after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Patient noticed a raised red rash on injection site 3 days after vaccination), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 21-Feb-2021.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE RASH (Patient noticed a raised red rash on injection site 3 days after vaccination). On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches). At the time of the report, VACCINATION SITE RASH (Patient noticed a raised red rash on injection site 3 days after vaccination), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  Treatment details include an antibody infusion on 23FEB2021.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise
Clinical narrative: felt bad; Stuck in bed; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On 28-Feb-2021, the patient experienced FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed). At the time of the report, FEELING ABNORMAL (felt bad) and MALAISE (Stuck in bed) outcome was unknown.            No concomitant medications or treatment details reported.   This case was linked.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lip blister, Mouth ulceration, Pyrexia
Clinical narrative: Fever Blisters (Lip); Ulcers (Mouth); Fever; This spontaneous case was reported by a consumer and describes the occurrence of LIP BLISTER (Fever Blisters (Lip)), MOUTH ULCERATION (Ulcers (Mouth)) and PYREXIA (Fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced LIP BLISTER (Fever Blisters (Lip)), MOUTH ULCERATION (Ulcers (Mouth)) and PYREXIA (Fever). At the time of the report, LIP BLISTER (Fever Blisters (Lip)), MOUTH ULCERATION (Ulcers (Mouth)) and PYREXIA (Fever) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Miosis, Tinnitus
Clinical narrative: Ringing in right ear; Pinpoint pupils; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in right ear) and MIOSIS (Pinpoint pupils) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included MELOXICAM (MELOXICAN) and VITAMINS NOS for an unknown indication.    On 28-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced TINNITUS (Ringing in right ear) and MIOSIS (Pinpoint pupils). At the time of the report, TINNITUS (Ringing in right ear) and MIOSIS (Pinpoint pupils) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included a high cholesterol medication and herbal supplements. No treatment details provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: Swollen arm; very tired; strong headache; strong pain in the arm; arm difficult to move; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (strong pain in the arm), MOBILITY DECREASED (arm difficult to move), PERIPHERAL SWELLING (Swollen arm), HEADACHE (strong headache) and FATIGUE (very tired) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (strong pain in the arm), MOBILITY DECREASED (arm difficult to move) and HEADACHE (strong headache). On 19-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm) and FATIGUE (very tired). On 21-Jan-2021, PAIN IN EXTREMITY (strong pain in the arm), MOBILITY DECREASED (arm difficult to move), PERIPHERAL SWELLING (Swollen arm), HEADACHE (strong headache) and FATIGUE (very tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications Lisinopril. Treatment details were not provided.    This case was linked to MOD21-032007 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia, Rash
Clinical narrative: antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen; low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever; here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen), RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the). On an unknown date, the patient experienced LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen), RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment medicines include Antihistamine, Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Acne, Body temperature increased, Eye swelling, Headache, Ocular hyperaemia
Clinical narrative: face was swollen; red rash; "little pimples"; red and swollen eye; swollen eye; FEVER; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (allergic to seafood and pecan nuts)) and Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (headache). On 15-Feb-2021, the patient experienced PYREXIA (FEVER). On 16-Feb-2021, the patient experienced SWELLING FACE (face was swollen). 16-Feb-2021, the patient experienced RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, HEADACHE (headache) had resolved. On 17-Feb-2021, SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash) and PYREXIA (FEVER) had resolved. At the time of the report, ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature increased: 97 to 99.8°f (High) lasted 6 hours and temperature went from 97 to 99.8°F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications Lisinopril   This case was linked to MOD21-032007 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash erythematous, Swelling face
Clinical narrative: face was swollen; red rash; "little pimples"; red and swollen eye; swollen eye; FEVER; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (allergic to seafood and pecan nuts)) and Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (headache). On 15-Feb-2021, the patient experienced PYREXIA (FEVER). On 16-Feb-2021, the patient experienced SWELLING FACE (face was swollen). 16-Feb-2021, the patient experienced RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, HEADACHE (headache) had resolved. On 17-Feb-2021, SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash) and PYREXIA (FEVER) had resolved. At the time of the report, ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature increased: 97 to 99.8°f (High) lasted 6 hours and temperature went from 97 to 99.8°F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications Lisinopril   This case was linked to MOD21-032007 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a health care professional and describes the occurrence of DIZZINESS (Dizziness) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Sulfonamide allergy.    On 30-Jan-2021 at 11:15 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021 at 11:30 AM, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Vaccination site warmth
Clinical narrative: localized welt that was red; warm; itchy; rash; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (localized welt that was red), VACCINATION SITE WARMTH (warm), PRURITUS (itchy) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ERYTHEMA (localized welt that was red), VACCINATION SITE WARMTH (warm), PRURITUS (itchy) and RASH (rash). At the time of the report, ERYTHEMA (localized welt that was red), VACCINATION SITE WARMTH (warm), PRURITUS (itchy) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.